COLL
NASDAQ · Pharmaceuticals
Collegium Pharmaceutical Inc
$25.16
+1.49 (+6.29%)
Open$25.74
Previous Close$23.67
Day High$26.39
Day Low$24.32
52W High$50.79
52W Low$21.43
Volume—
Avg Volume663.4K
Market Cap799.89M
P/E Ratio16.69
EPS$1.11
SectorPharmaceuticals
Analyst Ratings
Strong Buy
14 analysts
Price Target
+91.4% upside
Current
$25.16
$25.16
Target
$48.15
$48.15
$33.48
$48.15 avg
$61.72
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 625.06M | 525.53M | 486.77M |
| Net Income | 50.35M | 38.10M | 68.71M |
| Profit Margin | 8.1% | 7.7% | 14.1% |
| EBITDA | 134.39M | 107.34M | 134.63M |
| Free Cash Flow | — | — | 97.48M |
| Rev Growth | +18.9% | +18.9% | +18.7% |
| Debt/Equity | 3.09 | 3.09 | 0.46 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |